Patients whose PLM is secondary to underlying conditions like RLS show improvement when these underlying conditions are treated. Symptomatically, patients who receive treatment with dopamine agonists and other medications notice an improvement in the nocturnal sleep quality, sleep efficiency, and sleep stages even though there is no significant reduction in the PLM index in the sleep study.